Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Hypertension

• Publication date

  2010-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1038/ajh.2010.144PMID 20634799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of interleukin-18 levels with global arterial function and early structural changes in men without cardiovascular disease.

  2010cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients

  2008cited by this paper
• Journal of Cardiovascular Magnetic Resonance Open Access Uncomplicated Obesity Is Associated with Abnormal Aortic Function Assessed by Cardiovascular Magnetic Resonance

  2008cited by this paper
• Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

  2008cited by this paper
• Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease

  2008cited by this paper
• Nonalcoholic Fatty Liver Disease and Carotid Atherosclerosis in Children

  2008cited by this paper
• Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2007cited by this paper
• Relationship of fibrinogen with arterial stiffness and wave reflections

  2007cited by this paper
• Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification.

  2007cited by this paper
• Central blood pressure measurements and antihypertensive therapy: a consensus document.

  2007cited by this paper
• Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.

  2007cited by this paper
• Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.

  2007cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

  2006cited by this paper
• Expert consensus document on arterial stiffness: methodological issues and clinical applications.

  2006cited by this paper
• Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease

  2006cited by this paper
• The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases

  2006cited by this paper
• Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States

  2006cited by this paper
• Fatty liver, carotid disease and gallstones: a study of age-related associations.

  2006cited by this paper
• Acute Systemic Inflammation Increases Arterial Stiffness and Decreases Wave Reflections in Healthy Individuals

  2005cited by this paper
• Endothelial Function: Cardiac Events

  2005cited by this paper
• Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study

  2005cited by this paper
• Nonalcoholic fatty liver disease and the metabolic syndrome

  2005cited by this paper
• Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

  2005cited by this paper
• Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece

  2005cited by this paper
• Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease

  2005cited by this paper
• Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Adiponectin and arterial stiffness.

  2005cited by this paper
• C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals

  2004cited by this paper
• Effect of caffeine on aortic elastic properties and wave reflection

  2003cited by this paper
• Nonalcoholic steatohepatitis: what we know in the new millennium

  2002cited by this paper
• Prospective Evaluation of a Method for Estimating Ascending Aortic Pressure From the Radial Artery Pressure Waveform

  2001cited by this paper
• Genesis of the normal and abnormal arterial pulse.

  2000cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis

  1998cited by this paper
• Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function.

  1997cited by this paper

• Clustering adipokines, metabolic, oxidative stress, and inflammatory markers associated with cardiovascular disease risk in patients with metabolic syndrome.

  2026cites this paper
• Abdominal Aortic Aneurysm and Liver Fibrosis: Clinical Evidence and Molecular Pathomechanisms

  2025cites this paper
• Arterial stiffness as a complication of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

  2025cites this paper
• Non-alcoholic fatty liver disease (NAFLD) and its association to cardiovascular disease: A comprehensive meta-analysis

  2025influential citation
• Unveiling NOSTRIN as a potential diagnostic marker of vascular impairment in MASLD

  2025cites this paper
• The Effect of Weekend and Holiday Resistance Training Combined With a Low-Fat, High-Protein Diet on Endothelial Function, Hepatic Steatosis, and Overall Systemic Health: A Case Report

  2025cites this paper
• Endocan in nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis.

  2025cites this paper
• Association Between High Sensitivity Cardiac Troponin and All-Cause and Cardiovascular Mortality in Adults at Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study

  2025cites this paper
• Relation between non-alcoholic fatty liver disease and carotid artery intimal media thickness as a surrogate for atherosclerosis: a systematic review and meta-analysis

  2024cites this paper
• Influence of MAFLD and NAFLD on arterial stiffness: A longitudinal cohort study.

  2024cites this paper
• Loss-of-function G6PD variant moderated high-fat diet-induced obesity, adipocyte hypertrophy, and fatty liver in male rats

  2024cites this paper
• Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease – a systematic review and meta-analysis

  2024cites this paper
• Evaluating the Arterial Stiffness as a Useful Tool in the Management of Obese Children

  2023cites this paper
• Association of nonalcoholic fatty liver disease and carotid media‐intima thickness: A systematic review and a meta‐analysis

  2023cites this paper
• Reactive Oxygen Species in the Aorta and Perivascular Adipose Tissue Precedes Endothelial Dysfunction in the Aorta of Mice with a High-Fat High-Sucrose Diet and Additional Factors

  2023cites this paper
• Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

  2022cites this paper
• Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes

  2022cites this paper
• Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals

  2022cites this paper
• Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review

  2022cites this paper
• Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease

  2022cites this paper
• Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease.

  2022cites this paper
• Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

  2022influential citation
• Fatty Liver Index is Positively Associated with Arterial Stiffness in a Chinese Cohort Undergoing Health Assessment

  2021cites this paper
• Mutation of the 5' untranslated region stem-loop mRNA structure reduces type I collagen deposition and arterial stiffness in male obese mice.

  2021cites this paper
• Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease

  2021cites this paper
• Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis

  2021cites this paper
• Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches

  2021cites this paper
• Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management

  2021cites this paper
• Relationship between circulating leptin levels and arterial stiffness: a systematic review and meta-analysis of observational studies

  2020cites this paper
• Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients

  2020cites this paper
• Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease

  2020cites this paper
• NAFLD and Cardiovascular and Cardiac Disease: Clinical Implications

  2020cites this paper
• Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study.

  2020cites this paper
• Non-Alcoholic Fatty Liver Disease: A 360-degree Overview

  2020cites this paper
• Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease

  2020influential citation
• An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease

  2020cites this paper
• The Role of Adipokines in the Development of Arterial Stiffness and Hypertension

  2020cites this paper
• Effect of resveratrol supplementation and interval exercise on heart cells apoptosis in male rats with non-alcoholic fatty liver

  2020cites this paper
• Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis

  2020cites this paper
• Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation

  2019cites this paper
• Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil.

  2019cites this paper
• Association of Non-Alcoholic Fatty Liver Disease with Increased Carotid Intima-Media Thickness Considering Other Cardiovascular Risk Factors

  2019cites this paper
• No association between aortic stiffness and liver steatosis in morbidly obese patients.

  2019cites this paper
• Non-alcoholic fatty liver disease: A growing public health problem in Turkey.

  2019cites this paper
• Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old

  2018cites this paper
• Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study

  2018cites this paper
• Assessment of Arterial Stiffness and Body Composition in Stable Liver Transplant Recipients.

  2018cites this paper
• Usefulness of controlled attenuation parameter for detecting increased arterial stiffness in general population.

  2018cites this paper
• The effect of combined therapy with resveratrol, and continuous and interval exercises on levels of apoptotic biomarkers in heart tissue of male rats with non-alcoholic fatty liver

  2018cites this paper
• Effects of chronic hepatitis C infection on arterial stiffness.

  2017cites this paper
• The role of non- alcoholic fatty liver disease (NAFLD)in the occurrence of CVDs through measuring carotid intima-media thickness

  2017cites this paper
• Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.

  2017cites this paper
• Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study.

  2017cites this paper
• Arterial Stiffness and Nonalcoholic Fatty Liver Disease: Which is the Chicken and Which is the Egg?

  2017cites this paper
• Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation.

  2017cites this paper
• Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women

  2017cites this paper
• Soy Improves Cardiometabolic Health and Cecal Microbiota in Female Low-Fit Rats

  2017cites this paper
• The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

  2017cites this paper
• Die nicht-alkoholische Fettlebererkrankung: Eine Systemerkrankung

  2017cites this paper
• Cardiovascular Risk Factors Accelerate Progression of Vascular Aging in the General Population: Results From the CRAVE Study (Cardiovascular Risk Factors Affecting Vascular Age)

  2017cites this paper
• Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease

  2017cites this paper
• Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis

  2017cites this paper
• Association of non‐alcoholic fatty liver disease with impaired endothelial function by flow‐mediated dilation: A meta‐analysis

  2016cites this paper
• Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort.

  2016cites this paper
• Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease

  2016cites this paper
• Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD

  2016cites this paper
• Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD.

  2016cites this paper
• Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance

  2016cites this paper
• NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?

  2016cites this paper
• Nonalcoholic fatty liver disease - A multisystem disease?

  2016cites this paper
• The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study

  2016cites this paper
• Non-alcoholic fatty liver disease–From the cardiologist perspective

  2016cites this paper
• Regular Exercise Reduces Endothelial Cortical Stiffness in Western Diet–Fed Female Mice

  2016cites this paper
• Nonalcoholic fatty liver disease as a multi-systemic disease.

  2016cites this paper
• Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio‐T2DM cohort study

  2016cites this paper
• Arterial hypertension, obesity and non-alcoholic fatty liver disease: is there any connection?

  2016cites this paper
• Heart Disease and the Liver: Interactions Between the Heart and the Liver

  2016cites this paper
• Fatty liver is an independent predictor of early carotid atherosclerosis.

  2016cites this paper
• Obesity and Metabolic Syndrome

  2015cites this paper
• Leptin is Associated with Local Stiffness of the Carotid Artery in Overweight Patients with Type 2 Diabetes

  2015cites this paper
• Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage?

  2015cites this paper
• Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.

  2015influential citation
• Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.

  2015cites this paper
• Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index

  2015influential citation
• Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes

  2015cites this paper
• S2k-Leitlinie nicht alkoholische Fettlebererkrankungen

  2015cites this paper
• Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

  2015cites this paper
• An update on the role of adipokines in arterial stiffness and hypertension.

  2015cites this paper
• Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.

  2015cites this paper
• Nonalcoholic fatty liver disease and vascular disease : State-ofthe-art WJG 20 th Anniversary Special Issues ( 12 ) : Nonalcoholic fatty liver disease

  2014cites this paper
• Nonalcoholic fatty liver disease and cardiovascular disease.

  2014cites this paper
• Markers of endothelial dysfunction in patients with non‐alcoholic fatty liver disease and coronary artery disease

  2014cites this paper
• Nonalcoholic fatty liver disease and cardiovascular disease.

  2014cites this paper
• Hemostatic factors and the metabolic syndrome.

  2014cites this paper
• Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

  2014cites this paper
• Non‐high‐density lipoprotein cholesterol independently predicts new onset of non‐alcoholic fatty liver disease

  2014cites this paper
• Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)

  2014cites this paper
• Increased whole blood viscosity associated with arterial stiffness in patients with non‐alcoholic fatty liver disease

  2014cites this paper
• Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes

  2014cites this paper
• Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population

  2014cites this paper